Introduction
============

Stomata, formed by a pair of guard cells, have developed the ability to respond to various environmental signals ([@B22]). Environmental signals such as darkness or CO~2~ concentration and a plant hormone abscisic acid (ABA) are major factors triggering the stomatal closure response. The signals perceived by stomata activate intracellular molecules linked to a variety of signaling molecules ([@B15]). Previous studies on ABA signaling showed that the stomatal response is mediated by numerous cellular components. For example, phosphatidylinositol (PI) metabolism plays an important role in ABA-induced oscillations in guard cell cytosolic Ca^2+^ concentration (\[Ca^2+^\]~cyt~) ([@B24]). PI 3-phosphate (PI3P) and PI 4-phosphate (PI4P) are required for normal stomatal movements and are involved in the ABA-induced increase in \[Ca^2+^\]~cyt~ ([@B13]). cGMP pathways are involved in the increase in \[Ca^2+^\]~cyt~ by promoting Ca^2+^ release from intracellular stores ([@B8]). Nitric oxide (NO) synthesis is required for ABA-induced stomatal closure ([@B21]). Microtubule organization is also essential for stomatal movement ([@B18]; [@B12]). Furthermore, the SNARE complex controls guard cell ion channel activities ([@B17]; [@B25]; [@B6]). The mechanisms for environmental regulation of stomatal aperture are only now being elucidated because of the complex networks of signaling components involved ([@B3]). We hypothesize that components of the ABA signal transduction pathway may also be important for the environmental regulation of stomatal aperture.

The activity of the plasma membrane H^+^-ATPase that drives stomatal opening may be regulated downstream of the ABA signal transduction pathway. PATROL1, which was identified by a mutant impaired in stomatal opening in response to low CO~2~ and light, is hypothesized to deliver the H^+^-ATPase to plasma membranes by promoting the formation of SNARE complexes ([@B9]). Live cell imaging revealed that green fluorescent protein-tagged PATROL1 (GFP-PATROL1) is localized to dot-like structures adjacent to the plasma membranes in guard cells ([@B9]). The spatial density of the GFP-PATROL1 dots increased in guard cells with closed stomata treated with darkness or drought stress, suggesting downregulation of H^+^-ATPase activity by the PATROL1 internalization and a subsequent decrease in the amount of H^+^-ATPase in plasma membranes ([@B9]).

In this study, we performed a pharmacological study using inhibitors of a set of cellular components that included PI3K, PI4K, cGMP, Ca^2+^, small G-protein, the SNARE complex, and microtubules. We found that PAO (a PI4K inhibitor) and LY294002 (a PI3K inhibitor) specifically affected the stomatal response and PATROL1 dynamics in response to CO~2~ and darkness, respectively. These findings suggest the possibility that the products of PI metabolism including PI4P or PI3P selectively regulate stomatal movements depending on the environmental signals perceived in guard cells.

Materials and Methods {#s1}
=====================

Plant Materials
---------------

*Arabidopsis thaliana* (ecotype Columbia-0) plants were grown on solid 1/2 MS medium for 18 days in a growth chamber (constant white light of 80 μmol m^-2^ s^-1^ at 22--28°C and 30--60% relative humidity) after being stored at 4°C in the dark for 2 days. The plants were transplanted onto a nutrient solution composed of the following macronutrients: 1.25 mM KNO~3~, 0.5 mM Ca(NO~3~)~2~, 0.5 mM MgSO~4~, 0.625 mM KH~2~PO~4~, and the following micronutrients: 17.5 μM H~3~BO~3~, 12.5 μM Fe EDTA 3H~2~O, 3.5 μM MnCl~2~ 4H~2~O, 2.5 μM NaCl, 0.25 μM ZnSO~4~ 7H~2~O, 0.125 μM CuSO~4~ 5H~2~O, 0.05 μM Na~2~Mo~4~ 2H~2~O, and 0.0025 μM CoCl~2~ 6H~2~O. The final solution pH was 5.5. Plants at 22--24 days old were used to measure stomatal aperture. The transgenic line expressing GFP-PATROL1 was grown on solid 1/2 Murashige and Skoog (MS) medium for 7 days in a growth chamber (18/6 h light/dark cycle using white light of 60 μmol m^-2^ s^-1^ at 23.5°C). Cotyledons were used to measure stomatal aperture and GFP-PATROL1 dot densities.

Stomatal Aperture Measurements
------------------------------

To measure stomatal apertures in response to CO~2~, abaxial epidermal peels were floated on an opening medium containing 10 mM KCl, 25 mM MES-KOH (pH 6.15) and 1 mM CaCl~2~ and incubated in a growth chamber under white light (200 μmol m^-2^ s^-1^) for 1 h. To measure stomatal aperture in response to darkness and ABA, epidermal peels were floated on an opening medium containing 30 mM KCl, 5 mM MES-KOH (pH 6.15) and 1 mM CaCl~2~ and incubated in a growth chamber under white light (120 μmol m^-2^ s^-1^) for 1 h. The epidermal strips were transferred to darkness or the opening medium with or without 2 mM bicarbonate or 10 μM ABA and inhibitors and incubated for a further 2 h before stomatal apertures were measured.

Measurements of GFP-PATROL1 Dot Density
---------------------------------------

To evaluate the density of GFP-PATROL1 dots beneath plasma membranes quantitatively, we used transgenic seedlings grown on solid 1/2 MS medium for 7 days in growth chambers at 23.5°C with an 18/6 h light/dark cycle using 60 μmol m^-2^s^-1^ white lights. As a pretreatment, seedlings were immersed into 1.0 mL of opening buffer \[30 mM KCl, 0.1 mM CaCl~2~, 10 mM MES-KOH (pH 6.15)\] in microtubes for 1 h under white light (100 μmol m^-2^s^-1^). To examine the light/dark response, seedlings were transferred into 1.0 mL of the control solution \[opening buffer with 0.1% (v/v) DMSO\] or inhibitor solutions (opening buffer with 2.5 μM PAO or 70 μM LY294002) wrapped with or without aluminum foil to shield the solution from light, and placed in a 23.5°C chamber with 100 μmol m^-2^s^-1^ white lights for 2--3 h. To examine the ABA response, seedlings were transferred into 1.0 mL of the control solution or inhibitor solutions with or without 10 μM ABA, and placed in a 23.5°C chamber with 100 μmol m^-2^s^-1^ white lights for 2--3 h. To examine the CO~2~ response, seedlings were transferred into 1.0 mL of the control solution or inhibitor solutions with or without 2 mM CsHCO~3~ (Sigma--Aldrich), and placed in a 23.5°C chamber with 100 μmol m^-2^s^-1^ white lights for 2--3 h. Cesium bicarbonate was used as the source of CO~2~ in all experiments. Cotyledons were mounted on glass slides and observed under a variable-angle epifluorescence microscope (IX-73; Olympus) equipped with a total internal reflection microscopy unit (IX3-RFAEVAW; Olympus) and an electron multiplying charge-coupled device camera head system (ImagEM; Hamamatsu Photonics). Time-sequential images were captured using the 'Acquire-Stream Acquisition' feature of MetaMorph software (Molecular Devices) with 300 frames at 100 ms exposure time to obtain the maximum intensity projection images. The numbers of GFP-PATROL1 dots in the maximum intensity projection images were counted using the 'Process-Find Maxima...' feature of ImageJ software ([@B1]). Cell areas that were manually segmented were measured using the 'Analyze-Measure' feature of ImageJ software, and the GFP-PATROL1 dot densities per unit cell area were calculated.

Chemicals
---------

PAO (Sigma), LY294002 (2-morpholin-4-yl-8-phenylchromen-4-one) (Tokyo Chemical Industry), LY83583 \[6-(phenylamino)-5,8-dihydroquinoline-5,8-dione\] (Cayman Chemical Company), brefeldin A ((1*R*,2*E*,6*S*,10*E*,11a*S*,13*S*,14a*R*)-1,13-dihydroxy-6-methyl-1,6,7,8,9,11a,12,13,14,14a-decahydro-4*H*-cyclopenta \[*f*\]oxacyclotridecin-4-one) (Wako Pure Chemical Industries), W-7 \[*N*-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride\] (Wako Pure Chemical Industries), *N*-ethylmaleimide (1-ethylpyrrole-2,5-dione) (Tokyo Chemical Industry), and propyzamide (Wako Pure Chemical Industries) stock solutions (100 mM) were prepared in 100% DMSO.

Results
=======

The PI4K Inhibitor Specifically Inhibited CO~2~-Induced Stomatal Closure, Whereas the PI3K Inhibitor Specifically Inhibited Darkness-Induced Stomatal Closure
-------------------------------------------------------------------------------------------------------------------------------------------------------------

To confirm that stomatal guard cells respond to CO~2~, darkness, and ABA treatment, we assayed stomatal closure in epidermal strips of mature *A. thaliana*. Treatments with 2 mM bicarbonate, darkness, and 10 μM ABA led to significant decreases in the average stomatal aperture compared with the control condition (**Figure [1](#F1){ref-type="fig"}**). This result verifies that guard cells on *A. thaliana* epidermal strips function in response to CO~2~, darkness, and ABA treatment.

![**Stomatal closure induced by bicarbonate, darkness, or abscisic acid (ABA) on stripped epidermal peels of *Arabidopsis thaliana*.** The epidermal strips were placed in opening buffer for 1 h in white light before being transferred to darkness or opening buffer containing 2 mM bicarbonate or 10 μM ABA for 2 h. Error bars indicate ±SE, and asterisks represent a significant difference between treatments (*n* ≥ 120 stomata per each treatment from ten independent experiments; *P* \< 0.05, Student's *t*-test).](fpls-08-00677-g001){#F1}

Pharmacological tests to determine whether membrane trafficking is involved in the stomatal closure response to CO~2~, darkness, and ABA used inhibitors of PI4K (PAO), PI3K (LY294002), the cGMP pathway (LY83583), calmodulin (W-7), the SNARE complex (*N*-ethylmaleimide), G-proteins (brefeldin A), and microtubules (propyzamide) (**Table [1](#T1){ref-type="table"}** and **Figures [2](#F2){ref-type="fig"}**, **[3](#F3){ref-type="fig"}**). These inhibitors have been reported previously to inhibit their cellular component targets at the micromolar level. To exclude the possibility of non-specific effects at high inhibitor concentrations, inhibitor concentrations were selected that would lead to one-half inhibition of stomatal aperture changes compared with the control conditions. We defined the inhibition levels as shown in the **Figure [4](#F4){ref-type="fig"}**, thereby enabling quantitative comparisons of the effect of each inhibitor on the stomatal response (**Figure [4](#F4){ref-type="fig"}**).

###### 

Membrane trafficking inhibitors used in this study.

  Inhibitors           Inhibition targets      Inhibitor effects              Reference
  -------------------- ----------------------- ------------------------------ -----------
  Phenylarsine oxide   PI 4-phosphate (PI4P)   PI4K inhibition                [@B27]
  LY294002             PI3P                    PI3K inhibition                [@B26]
  LY83583              Cyclic GMP              Guanylyl cyclase inhibition    [@B19]
  W-7                  Calmodulin              Calmodulin inhibition          [@B14]
  *N*-Ethylmaleimide   SNARE complex           SNARE complex dissociation     [@B23]
  Brefeldin A          G protein               GNOM ARF-GEF inhibition        [@B20]
  Propyzamide          Microtubule             Microtubule depolymerization   [@B2]
                                                                              

![**Effects of membrane trafficking inhibitors on stomatal responses to bicarbonate, darkness, and ABA.** Epidermal strips were placed in opening buffer for 1 h in the light before being transferred to darkness or opening buffer containing 2 mM bicarbonate or 10 μM ABA with/without inhibitors (2.5 μM PAO, 70 μM LY294002, 70 μM LY83583, 70 μM W-7) for 2 h. Error bars indicate ±SE, and lowercase letters represent significantly different groups (*n* ≥ 120 stomata per each treatment from four or five independent experiments; *P* \< 0.05, Student's *t*-test).](fpls-08-00677-g002){#F2}

![**Effects of membrane trafficking inhibitors on stomatal responses to bicarbonate, darkness, and ABA.** Epidermal strips were placed in opening buffer for 1 h in the light before being transferred to darkness or opening buffer containing 2 mM bicarbonate or 10 μM ABA with/without inhibitors (20 μM *N*-ethylmaleimide, 70 μM brefeldin A, and 80 μM propyzamide) for 2 h. Error bars indicate ±SE, and lowercase letters represent significantly different groups (*n* ≥ 120 stomata per each treatment from four or five independent experiments; *P* \< 0.05, Student's *t*-test).](fpls-08-00677-g003){#F3}

![**Effects of membrane trafficking inhibitors on stomatal responses to bicarbonate, darkness, and ABA.** A representative graph of stomatal aperture measurements is given to illustrate the calculation of inhibition levels (right figure inset). Inhibition levels were calculated from the data shown in **Figures [2](#F2){ref-type="fig"}**, **[3](#F3){ref-type="fig"}** as the percentage difference in stomatal closure with(B)/without(A) the specific inhibitor based on the equation 100 × (1-B/A) (as shown in the figure inset). Values are presented as means ±SE, and lowercase letters represent significantly different groups (*n* ≥ 120 stomata per treatment from three independent experiments; *P* \< 0.05, Fisher's LSD test).](fpls-08-00677-g004){#F4}

When epidermal strips of mature leaves were treated with PAO, a PI4K inhibitor, stomatal apertures were reduced after bicarbonate, darkness, and ABA treatments by 83.5, 29.9, and 37.1%, respectively, compared with the control conditions (**Figures [2](#F2){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). A PI3K inhibitor LY294002 inhibited stomatal responses to bicarbonate, darkness, and ABA treatments by 17.4, 67.0, and 24.4%, respectively, compared with the control conditions (**Figures [2](#F2){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). PAO had a specific and stronger inhibitory effect on the stomatal response to CO~2~ compared with that of darkness and ABA. LY294002 also had a specific and stronger inhibitory effect on the stomatal response to darkness compared with that of CO~2~ and ABA. A cGMP inhibitor, LY83583, inhibited the stomatal responses to bicarbonate, darkness, and ABA treatments by 55.6, 41.2, and 76.1%, respectively, compared with the control conditions (**Figures [2](#F2){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). Treatment with LY83583 caused a slightly stronger inhibitory effect in the stomatal responses to ABA. A calmodulin antagonist, W-7, inhibited the stomatal responses to bicarbonate, darkness, and ABA treatments by 67.5, 51.3, and 52.3%, respectively, compared with the control conditions (**Figures [2](#F2){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). An inhibitor of the SNARE complex, *N*-ethylmaleimide, inhibited the stomatal responses to bicarbonate, darkness, and ABA treatments by 41.0, 57.0, and 61.3%, respectively, compared with the control conditions (**Figures [3](#F3){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). A small G-protein inhibitor, brefeldin A, inhibited 57.4, 57.8, and 41.0% of stomatal response to bicarbonate, darkness, and ABA treatments, respectively, compared with the control conditions (**Figures [3](#F3){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). W-7, *N*-ethylmaleimide, and brefeldin A had no specific inhibitory effects on the stomatal response to CO~2~, darkness, or ABA. An inhibitor of microtubule polymerization, propyzamide, inhibited the stomatal responses to bicarbonate, darkness, and ABA treatments by 53.6, 42.1, and 34.4%, respectively, compared with the control conditions (**Figures [3](#F3){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). Propyzamide treatment caused a slight but not significant difference in the inhibition of stomatal responses to CO~2~ and ABA.

PI4K and PI3K Inhibitors Specifically Inhibited the Increase in GFP-PATROL1 Dot Density in Response to CO~2~ and Darkness, Respectively
---------------------------------------------------------------------------------------------------------------------------------------

Specific inhibitory effects were observed in the stomatal response to CO~2~ and darkness when epidermal strips were treated with PAO and LY294002, respectively (**Figures [2](#F2){ref-type="fig"}**, **[4](#F4){ref-type="fig"}**). In guard cells, GFP-PATROL1 dot densities increase during stomatal closure ([@B9]). To further confirm the effects of PAO and LY294002 on the behavior of PATROL1 in response to CO~2~, darkness, and ABA, we measured GFP-PATROL1 dot density in the guard cells treated with 2 mM bicarbonate, darkness, and 10 μM ABA in the presence of PAO and LY294002. Young seedlings (7-days-old) were used in this experiment because preliminary analyses demonstrated that there is a significant reduction in GFP-PATROL1 fluorescence in the guard cells of mature leaves. Further tests showed that GFP-PATROL1 dots were eliminated with a 70 μM LY294002 treatment. Furthermore, the 30 μM LY294002 treatment was sufficient for inhibiting darkness-induced PATROL1 dynamics under our experimental conditions. Therefore, subsequent experiments used 30 μM LY294002.

The stomatal closure assay using cotyledons expressing GFP-PATROL1 showed a similar trend in the responsiveness to CO~2~, darkness, and ABA between cotyledonary leaves and mature leaves when exposed to PAO and LY294002 (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}). Time-sequential images of GFP-PATROL1 movement showed that GFP-PATROL1 dot appeared in response to 2 mM bicarbonate, darkness, or 10 μM ABA treatment in guard cells (Supplementary Figures [S3](#SM1){ref-type="supplementary-material"}, [S4](#SM1){ref-type="supplementary-material"}) and resulted in significant increases in PATROL1 dot densities (**Figure [5](#F5){ref-type="fig"}**). These results suggest that activation of PATROL1 dynamics is essential for its function in the environmental signal transduction pathways. Compared with the control condition, PAO treatment significantly inhibited the appearance of GFP-PATROL1 dots (Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}) and the increase in GFP-PATROL1 dot density in cotyledons after bicarbonate treatment (**Figure [5A](#F5){ref-type="fig"}**). Treatment with LY294002 also led to a significant inhibition in the appearance of GFP-PATROL1 dots (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}) and in the increase in GFP-PATROL1 dot density in cotyledons treated with darkness (**Figure [5B](#F5){ref-type="fig"}**). Taken together, these results show that PI4K and PI3K may contribute to stomatal closure and PATROL1 dynamics in response to CO~2~ and darkness, respectively.

![**Effects of PAO and LY294002 on GFP-PATROL1 dot densities in cotyledonary guard cells in response to bicarbonate, darkness, and ABA.** **(A)** Cotyledons were placed in opening buffer for 1 h in white light before being transferred to darkness or opening buffer containing 2 mM bicarbonate or 10 μM ABA with/without 2.5 μM PAO for 2 h. Error bars indicate ±SE of 12 independent experiments, and lowercase letters represent significantly different groups (*P* \< 0.05, Mann--Whitney's *U*-test). **(B)** Cotyledons were placed in opening buffer for 1 h in white light before being transferred to darkness or opening buffer containing 2 mM bicarbonate or 10 μM ABA with/without 30 μM LY294002 for 2 h. Error bars indicate ±SE of 12 independent experiments, and lowercase letters represent significantly different groups (*P* \< 0.05, Turkey-kramer's test).](fpls-08-00677-g005){#F5}

Discussion
==========

We used several specific inhibitors to determine how certain cellular components in guard cells contribute to the stomatal closure response to CO~2~, darkness, and ABA. Some previous inhibitor studies ([@B13]; [@B5]; [@B12]) determined where the inhibitors act in the ABA signal transduction pathways; however, it remains unknown how these cellular components are involved in the environmental signal transduction pathways. In this study, we show that PI4K and PI3K modulate signal transduction pathways in the stomatal response to CO~2~ and darkness, respectively. The concentrations of inhibitors used in this study were chosen to not inhibit the stomatal closure response completely, but to enable a comprehensive investigation of the inhibitory effects on the stomatal response to CO~2~, darkness, and ABA. PIs in guard cells are reported to be involved in several aspects of stomatal movement. PI4P and PI3P mediate \[Ca^2+^\]~cyt~ increase in response to ABA ([@B13]). PI(3,5)P~2~ is required for acidification of vacuoles in *Vicia faba* guard cells during ABA-induced stomatal closure ([@B4]). In addition, PI(4,5)P~2~ is important for light-induced stomatal opening ([@B16]) and ABA-induced closing responses ([@B11]). These results imply that PIs affect not only the known regulatory mechanisms for stomatal movements but also the complex networks of environmental signal transduction. We propose that our study also provides new mechanistic insight into the sensing and transduction pathways of environmental signals.

We observed similar levels of stomatal closure inhibition among bicarbonate, darkness, and ABA when epidermal strips were treated with W-7, brefeldin A, and *N*-ethylmaleimide (**Figure [4](#F4){ref-type="fig"}**). These results implied that calmodulin, cGMP, and the SNARE complex are involved in stomatal closure signaling irrespective of environmental factors. These components might act in a downstream signaling network that is activated by various environmental signals. Alternatively, there may be non-specific effects of these inhibitors, even when using concentrations that inhibit changes in stomatal closure by one-half compared with the control condition. LY83583 inhibited stomatal closure in response to ABA stronger than the response to darkness (**Figure [4](#F4){ref-type="fig"}**), implying that cGMP is more associated with ABA signaling than the environmental signal transduction pathways. This finding is consistent with a report that cGMP acts downstream of H~2~O~2~ and NO in the signaling pathway by which ABA induces stomatal closure ([@B5]). We also observed a stronger inhibition of stomatal response to CO~2~ compared with ABA when epidermal strips were exposed to propyzamide (**Figure [4](#F4){ref-type="fig"}**). Propyzamide inhibits stomatal opening induced by light ([@B18]) but does not inhibit stomatal closure induced by ABA ([@B12]). These results imply that microtubules are also involved in the environmental signal transduction pathway for stomatal responses.

Previously, [@B10] found that 20 μM LY294002 did not perturb the appearance of GFP-PATROL1 dots, whereas the GFP-PATROL1 dots disappeared with 20 μM PAO treatment. In this study, 20 μM LY294002 did not affect stomatal closure in response to CO~2~, darkness, and ABA (Supplementary Figure [S2](#SM1){ref-type="supplementary-material"} nor the activity of GFP-PATROL1. However, the GFP-PATROL1 dot densities as well as stomatal movements were inhibited by 2.5 μM PAO and 30 μM LY294002 (**Figure [5](#F5){ref-type="fig"}**). These observations indicate that PI4K and PI3K also regulate PATROL1 dynamics. Recently, PI4K and PI3K were reported to have distinct roles in intracellular trafficking of cellulose synthase complexes (CESA) ([@B7]). PI4K is required for the internalization of GFP-CESA3 from the plasma membrane to Golgi apparatus. In contrast, PI3K has a role in secretion and/or recycling to the plasma membrane ([@B7]). Although it is not clear whether the role is direct or indirect, the reduced PATROL1 dynamics after PAO and LY294002 treatment may reflect the existence of unknown mechanisms involving PI4K and PI3K in the differential regulation of PATROL1 dynamics. In this study, we showed that PI4K and PI3K are involved in the intermediate steps between the sensing of environmental signals and membrane trafficking systems. Further studies will be needed to elucidate mechanisms of PI metabolism for sensing of environmental signals; such studies will also be effective in elucidating the possible coordination between PI metabolism and membrane trafficking systems.
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